Skip to main content

Hyperaggregability of Platelets in Patients with Hyperlipoproteinemia Type IIb Under Treatment with Etofibrate Retard and Acetylsalicylic Acid

  • Conference paper
Drugs Affecting Lipid Metabolism

Part of the book series: Proceedings in Life Sciences ((LIFE SCIENCES))

  • 210 Accesses

Abstract

Heightened platelet function is suggested to be associated with the well-known thrombotic complications and the accelerated atherogenesis of type II hyperlipoproteinemia (Carvalho et al. 1974). With regard to the two main theories on the pathogenesis of atherosclerosis, the hypothesis of damaged endothelium and the lipid hypothesis, one has to distinguish between cause and effect. On the one side, it is not imperative that endothelial damage by rheological, metabolic, traumatic, or inflammatory causes resuits in atherosclerotic plaques. On the other hand, one can expect this with a much higher probability if such endothelial lesions occur in patients with hypercholesterolemia. The pathogenesis of atherosclerosis is founded upon many facts and atherosclerosis is the multifactorial result of parts of the lipid hypothesis as well as of the hypothesis of damaged endothelium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Augustin J (1984) Die Lipidhypothese. Herz Gefäße 4:201–202

    Google Scholar 

  • Carvalho A, Colman R, Lees R (1974) Platelet function in hyperlipoproteinemia. N Engl J Med 290:434–438

    Article  PubMed  CAS  Google Scholar 

  • Hawkins RI (1972) Smoking, platelets and thrombosis. Nature (London) 236:450–455

    Article  CAS  Google Scholar 

  • Hirsch PD, Campbell WB, Willerson JT, Hillis LD (1981) Prostaglandins and ischemic heart disease. Am J Med 71:1009–1014

    Article  Google Scholar 

  • Krüger B, Sörgel F, Kirchberg HG, Pällmann U, Geldmacher von Malinckrodt M, Lang E (1983) Einfluß von Etofibrat auf die Aggregation der Blutplättchen. Therapiewoche 33:3297–3299

    Google Scholar 

  • Weber PC, Siess W, Scherer B (1979) Vaskuläre, thrombozytäre und renale Prostaglandine. Biochemie, Funktion und klinische Aspekte. Klin Wochenschr 57:425–435

    Article  PubMed  CAS  Google Scholar 

  • Wennmalm A (1982) Interaction of nicotine and prostaglandins in the cardiovascular system. Prostaglandins 23:139–144

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Krüger, B., Thiemann, R. (1987). Hyperaggregability of Platelets in Patients with Hyperlipoproteinemia Type IIb Under Treatment with Etofibrate Retard and Acetylsalicylic Acid. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_73

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71702-4_73

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71704-8

  • Online ISBN: 978-3-642-71702-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics